Cannabis consumers are crazy about their vape pens. And that demand is huge, and growing. According to cannabis market research group Arcview Market Research in partnership with BDS Analytics, the cannabis concentrates market was worth nearly $3 billion in 2018, an increase of 49 percent from the previous year. Vaping is leading the surge, with 58 percent of concentrate sales coming from prefilled vaporizers.
However, over the past few months, more than 450 people have been sickened with lung problems linked to contaminants in illicit market vape carts. As of press time, seven people have died from complications, exhibiting symptoms similar to lipoid pneumonia, a rare inflammatory condition found when fat particles enter the lungs. Hospitalized patients — many of them young and healthy — have reported difficulty breathing, nausea, vomiting, diarrhea, fatigue, weight loss and coughing up blood.
In response, President Donald Trump announced that he is working to finalize a ban on flavored e-cigarettes. The problem? It may be drug policy, not flavored e-cigs, that is really responsible for the rash of respiratory-related illnesses. Aaron Smith, executive director of the National Cannabis Industry Association (NCIA), an advocacy organization working to promote the growth of a responsible and legitimate cannabis